1.Matrix metalloproteinase-8 inhibitors mitigate sepsis-induced myocardial injury in rats.
Xiaorui ZHOU ; Jiakai LU ; Dong CHEN ; Wei WANG ; Qing CAI ; Tongxun LI ; Jinglan ZHANG
Chinese Medical Journal 2014;127(8):1530-1535
BACKGROUNDSepsis-induced myocardial injury (SIMI) is caused by a variety of mechanisms. The aim of the study is to investigate the effects of metalloproteinase-8 (MMP-8) on SIMI and its mechanisms in rats.
METHODSForty male Sprague Dawley rats were randomly divided into four groups: MMP-8 inhibitor (M8I), dexamethasone (DEX), sepsis, and sham groups. The sepsis model was established by cecal ligation and puncture (CLP). Rats in the M8I group immediately received an intraperitoneal injection of M8I (0.1 mg/kg) after CLP. Rats in the DEX group immediately received an intraperitoneal (IP) injection of DEX (2 mg/kg). Rats in the sepsis and sham groups received intraperitoneal injections of normal saline. Rats were sacrificed 12 hours after CLP. Paraffin sections were stained with hematoxylin and eosin to observe the myocardium. The myocardial ultrastructure was observed with transmission electron microscopy. MMP-8, tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) were detected by immunohistochemistry. The expression of MMP-8 was measured by Western blotting. TNF-α and IL-1β levels in serum and myocardial tissue were determined by enzyme-linked immunosorbent assay.
RESULTSCompared with the sham group, the myocardium in the sepsis group was seriously injured. MMP-8, TNF-α and IL-1β expression was higher in the sepsis group than in the sham group. Treatment with M8I or DEX, however, attenuated sepsis induced histopathological changes in the heart, and was associated with significant reductions in serum and myocardial levels of TNF-α and IL-1β (P < 0.05). M8I significantly inhibited MMP-8 expression in myocardial tissue (P < 0.05). In addition, treatment with DEX was not associated with a change in myocardial levels of MMP-8 (P > 0.05).
CONCLUSIONMMP-8 inhibitor attenuated myocardial injury in septic rats, which might be related to reduced expression of TNF-α and IL-1β.
Animals ; Dexamethasone ; therapeutic use ; Disease Models, Animal ; Enzyme-Linked Immunosorbent Assay ; Heart Diseases ; drug therapy ; etiology ; Interleukin-1beta ; metabolism ; Male ; Matrix Metalloproteinase 8 ; metabolism ; Matrix Metalloproteinase Inhibitors ; therapeutic use ; Rats ; Rats, Sprague-Dawley ; Sepsis ; complications ; drug therapy ; Tumor Necrosis Factor-alpha ; metabolism
2.Aqueous extract of Epimedium sagittatum mitigates pulmonary fibrosis in mice.
Ru WANG ; Fei-Yue HOU ; Meng-Nan ZENG ; Bei-Bei ZHANG ; Qin-Qin ZHANG ; Shuang-Shuang XIE ; Wei-Sheng FENG ; Xiao-Ke ZHENG
China Journal of Chinese Materia Medica 2023;48(20):5612-5622
This study aims to investigate the intervention effect of the aqueous extract of Epimedium sagittatum Maxim on the mouse model of bleomycin(BLM)-induced pulmonary fibrosis, so as to provide data support for the clinical treatment of pulmonary fibrosis. Ninety male C57BL/6N mice were randomized into normal(n=10), model(BLM, n=20), pirfenidone(PFD, 270 mg·kg~(-1), n=15), and low-, medium-, and high-dose E. sagittatum extract(1.67 g·kg~(-1), n=15; 3.33 g·kg~(-1), n=15; 6.67 g·kg~(-1), n=15) groups. The model of pulmonary fibrosis was established by intratracheal instillation of BLM(5 mg·kg~(-1)) in the other five groups except the normal group, which was treated with an equal amount of normal saline. On the day following the modeling, each group was treated with the corresponding drug by gavage for 21 days. During this period, the survival rate of the mice was counted. After gavage, the lung index was calculated, and the morphology and collagen deposition of the lung tissue were observed by hematoxylin-eosin(HE) and Masson staining, respectively. The levels of reactive oxygen species(ROS) in lung cell suspensions were measured by flow cytometry. The levels of glutathione peroxidase(GSH-Px), total superoxide dismutase(T-SOD), and malondialdehyde(MDA) the in lung tissue were measured. Terminal-deoxynucleoitidyl transferase-mediated nick-end labeling(TUNEL) was employed to examine the apoptosis of lung tissue cells. The content of interleukin-6(IL-6), chemokine C-C motif ligand 2(CCL-2), matrix metalloproteinase-8(MMP-8), transforming growth factor-beta 1(TGF-β1), alpha-smooth muscle actin(α-SMA), E-cadherin, collagen Ⅰ, and fibronectin in the lung tissue was measured by enzyme-linked immunosorbent assay(ELISA). The expression levels of F4/80, Ly-6G, TGF-β1, and collagen Ⅰ in the lung tissue were determined by immunohistochemistry. The mRNA levels of CCL-2, IL-6, and MMP-7 in the lung tissue were determined by qRT-PCR. The content of hydroxyproline(HYP) in the lung tissue was determined by alkaline hydrolysation. The expression of α-SMA and E-cadherin was detected by immunofluorescence, and the protein levels of α-SMA, vimentin, E-cadherin in the lung tissue were determined by Western blot. The results showed the aqueous extract of E. sagittatum increased the survival rate, decreased the lung index, alleviated the pathological injury, collagen deposition, and oxidative stress in the lung tissue, and reduced the apoptotic cells. Furthermore, the aqueous extract of E. sagittatum down-regulated the protein levels of F4/80 and Ly-6G and the mRNA levels of CCL-2, IL-6, and MMP-7 in the lung tissue, reduced the content of IL-6, CCL-2, and MMP-8 in the alveolar lavage fluid. In addition, it lowered the levels of HYP, TGF-β1, α-SMA, collagen Ⅰ, fibronectin, and vimentin, and elevated the levels of E-cadherin in the lung tissue. The aqueous extract of E. sagittatum can inhibit collagen deposition, alleviate oxidative stress, and reduce inflammatory response by regulating the expression of the molecules associated with epithelial-mesenchymal transition, thus alleviating the symptoms of bleomycin-induced pulmonary fibrosis in mice.
Mice
;
Male
;
Animals
;
Pulmonary Fibrosis/metabolism*
;
Transforming Growth Factor beta1/metabolism*
;
Epimedium/metabolism*
;
Fibronectins/metabolism*
;
Matrix Metalloproteinase 7/therapeutic use*
;
Matrix Metalloproteinase 8/therapeutic use*
;
Vimentin/metabolism*
;
Interleukin-6/metabolism*
;
Mice, Inbred C57BL
;
Lung
;
Collagen/metabolism*
;
Bleomycin/toxicity*
;
RNA, Messenger/metabolism*
;
Cadherins/metabolism*
3.Effect of Helicobacter pylori Eradication According to the IL-8-251 Polymorphism in Koreans.
Hae Yeon KANG ; Sang Gyun KIM ; Mi Kyung LEE ; Joo Sung KIM ; Hyun Chae JUNG ; In Sung SONG
Journal of Korean Medical Science 2012;27(10):1202-1207
Previous studies suggested that polymorphisms of proinflammatory cytokine genes are important host genetic factors in Helicobacter pylori infection. The present study evaluated whether IL-8-251 polymorphism affected H. pylori eradication rate and to investigate the effect of H. pylori eradication on angiogenesis and the inflammatory process according to the IL-8-251 polymorphism. A total of 250 H. pylori-positive patients treated by endoscopic resection of the gastric neoplasm were classified into 3 groups (134 H. pylori-eradicated group, 19 H. pylori-eradication failure group, and 97 H. pylori-infected group). H. pylori status, histology, and angiogenic factor levels were evaluated at baseline, 6 months, and 18 months. H. pylori eradication rate was 92.9% in AA genotype, 85.7% in AT genotype and 88.4% in TT genotype (P value = 0.731). Elevated IL-8 and matrix metalloproteinase-9 concentrations in H. pylori-infected gastric mucosa were reversible by successful eradication of H. pylori, independent of the IL-8-251 polymorphism. It is suggested that elevated IL-8 and MMP-9 concentrations in H. pylori-infected gastric mucosa are altered significantly after successful eradication and these conditions continue for 18 months. However, IL-8-251 polymorphism does not affect H. pylori eradication rate and the sequential changes of related angiogenic factors after H. pylori eradication in Koreans.
Aged
;
Alleles
;
Angiopoietin-1/analysis
;
Anti-Bacterial Agents/therapeutic use
;
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
;
Asian Continental Ancestry Group/*genetics
;
Female
;
Gastric Mucosa/metabolism/pathology
;
Genotype
;
Helicobacter Infections/*drug therapy
;
*Helicobacter pylori
;
Humans
;
Interleukin-8/analysis/*genetics
;
Male
;
Matrix Metalloproteinase 9/analysis
;
Middle Aged
;
*Polymorphism, Single Nucleotide
;
Proton Pump Inhibitors/therapeutic use
;
Republic of Korea
;
Retrospective Studies
;
Stomach Neoplasms/pathology/surgery
;
Time Factors
;
Vascular Endothelial Growth Factor A/analysis
4.Micromolar sodium fluoride mediates anti-osteoclastogenesis in Porphyromonas gingivalis-induced alveolar bone loss.
Ujjal K BHAWAL ; Hye-Jin LEE ; Kazumune ARIKAWA ; Michiharu SHIMOSAKA ; Masatoshi SUZUKI ; Toshizo TOYAMA ; Takenori SATO ; Ryota KAWAMATA ; Chieko TAGUCHI ; Nobushiro HAMADA ; Ikuo NASU ; Hirohisa ARAKAWA ; Koh SHIBUTANI
International Journal of Oral Science 2015;7(4):242-249
Osteoclasts are bone-specific multinucleated cells generated by the differentiation of monocyte/macrophage lineage precursors. Regulation of osteoclast differentiation is considered an effective therapeutic approach to the treatment of bone-lytic diseases. Periodontitis is an inflammatory disease characterized by extensive bone resorption. In this study, we investigated the effects of sodium fluoride (NaF) on osteoclastogenesis induced by Porphyromonas gingivalis, an important colonizer of the oral cavity that has been implicated in periodontitis. NaF strongly inhibited the P. gingivalis-induced alveolar bone loss. That effect was accompanied by decreased levels of cathepsin K, interleukin (IL)-1β, matrix metalloproteinase 9 (MMP9), and tartrate-resistant acid phosphatase, which were up-regulated during P. gingivalis-induced osteoclastogenesis. Consistent with the in vivo anti-osteoclastogenic effect, NaF inhibited osteoclast formation caused by the differentiation factor RANKL (receptor activator of nuclear factor κB ligand) and macrophage colony-stimulating factor (M-CSF). The RANKL-stimulated induction of the transcription factor nuclear factor of activated T cells (NFAT) c1 was also abrogated by NaF. Taken together, our data demonstrate that NaF inhibits RANKL-induced osteoclastogenesis by reducing the induction of NFATc1, ultimately leading to the suppressed expression of cathepsin K and MMP9. The in vivo effect of NaF on the inhibition of P. gingivalis-induced osteoclastogenesis strengthens the potential usefulness of NaF for treating periodontal diseases.
Acid Phosphatase
;
drug effects
;
Alveolar Bone Loss
;
microbiology
;
prevention & control
;
Animals
;
Anti-Bacterial Agents
;
therapeutic use
;
Anti-Inflammatory Agents
;
therapeutic use
;
Bacteroidaceae Infections
;
microbiology
;
prevention & control
;
Bone Density Conservation Agents
;
therapeutic use
;
Cathepsin K
;
drug effects
;
Interleukin-1beta
;
drug effects
;
Interleukin-6
;
analysis
;
Interleukin-8
;
drug effects
;
Isoenzymes
;
drug effects
;
Macrophage Colony-Stimulating Factor
;
drug effects
;
Male
;
Matrix Metalloproteinase 9
;
drug effects
;
Osteoclasts
;
drug effects
;
Periodontitis
;
microbiology
;
prevention & control
;
Porphyromonas gingivalis
;
drug effects
;
RANK Ligand
;
drug effects
;
Rats
;
Rats, Sprague-Dawley
;
Sodium Fluoride
;
therapeutic use
;
Tartrate-Resistant Acid Phosphatase
;
Transcription Factors
;
drug effects
;
X-Ray Microtomography
;
methods